S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care
Dec 15, 2023•16 min•Season 4Ep. 20
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.
For the best experience, listen in Metacast app for iOS or Android